Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
PLAA (gene)
Introduction
Phospholipase A2-activating protein, also known as PLAA, is a human gene.[1]
Further reading
Further reading
- Clark MA, Ozgür LE, Conway TM; et al. (1991). “Cloning of a phospholipase A2-activating protein”. Proc. Natl. Acad. Sci. U.S.A. 88 (12): 5418–22. PMID 2052621.
- Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. PMID 9373149.
- Chopra AK, Ribardo DA, Wood TG; et al. (1999). “Molecular characterization of cDNA for phospholipase A2-activating protein”. Biochim. Biophys. Acta. 1444 (1): 125–30. PMID 9931468.
- Ruiz A, Nadal M, Puig S, Estivill X (1999). “Cloning of the human phospholipase A2 activating protein (hPLAP) gene on the chromosome 9p21 melanoma deleted region”. Gene. 239 (1): 155–61. PMID 10571045.
- Beatty BG, Qi S, Pienkowska M; et al. (2000). “Chromosomal localization of phospholipase A2 activating protein, an Ets2 target gene, to 9p21”. Genomics. 62 (3): 529–32. doi:10.1006/geno.1999.5999. PMID 10644453.
- Seigneurin-Berny D, Verdel A, Curtet S; et al. (2001). “Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways”. Mol. Cell. Biol. 21 (23): 8035–44. doi:10.1128/MCB.21.23.8035-8044.2001. PMID 11689694.
- Kozlenkov A, Manes T, Hoylaerts MF, Millán JL (2002). “Function assignment to conserved residues in mammalian alkaline phosphatases”. J. Biol. Chem. 277 (25): 22992–9. doi:10.1074/jbc.M202298200. PMID 11937510.
- Strausberg RL, Feingold EA, Grouse LH; et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
- Koumanov K, Momchilova A, Wolf C (2004). “Bimodal regulatory effect of melittin and phospholipase A2-activating protein on human type II secretory phospholipase A2”. Cell Biol. Int. 27 (10): 871–7. PMID 14499668.
- Ota T, Suzuki Y, Nishikawa T; et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Humphray SJ, Oliver K, Hunt AR; et al. (2004). “DNA sequence and analysis of human chromosome 9”. Nature. 429 (6990): 369–74. doi:10.1038/nature02465. PMID 15164053.
- Gerhard DS, Wagner L, Feingold EA; et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
- Rual JF, Venkatesan K, Hao T; et al. (2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.